Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Cancer|January 18, 2006
Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanomaTimothy M Pawlik, Merrick I Ross, Victor G Prieto, et al.
Cancer|September 24, 2004
Use of inferior vena caval filters and survival in patients with malignancyMichael J Wallace, James L Jean, Sanjay Gupta, et al.
Annals of Surgical Oncology|July 16, 2005
Predictors and natural history of in-transit melanoma after sentinel lymphadenectomyTimothy M Pawlik, Merrick I Ross, Marcella M Johnson, et al.
Cancer|October 26, 2006
Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanomaChristopher J Gannon, Dennis L Rousseau, Merrick I Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Expression of thyrotropin-releasing hormone by human melanoma and neviJulie A Ellerhorst, Aresu A Naderi, Marilyn K Johnson, et al.
Cancer|October 29, 2009
Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysisEric Jonasch, Paul Corn, Lance C Pagliaro, et al.
Cancer Causes & Control : CCC|May 17, 2003
Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States)Kim-Anh Do, Marcella M Johnson, Dorota A Doherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanomaThomas A Aloia, Jeffrey E Gershenwald, Robert H Andtbacka, et al.
Leukemia Research|March 21, 2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's diseaseMaher Albitar, Julie M Vose, Marcella M Johnson, et al.
Leukemia Research|May 4, 2004
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphomaFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Pageof 6